Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/13/2025 07:09 PDT] ACET Expected to Trade Up After Bullish Patterns Develop
• [05/12/2025 10:30 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Up By 100% ($0.61) From $0.61 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/12/2025 10:30 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Up By 100% ($0.6) From $0.6 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/07/2025 12:04 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Down By 100% ($0.62) From $0.62 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [05/07/2025 06:54 PDT] ACET Expected to Trade Up After Bullish Patterns Develop
• [05/02/2025 15:33 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Up By 100% ($0.59) From $0.59 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/29/2025 07:39 PDT] ACET Expected to Trade Down After Bearish Patterns Develop
• [04/25/2025 07:42 PDT] ACET Expected to Trade Up After Bullish Patterns Develop
• [04/16/2025 07:17 PDT] ACET Expected to Trade Up After Bullish Patterns Develop
• [04/09/2025 12:42 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Down By 100% ($0.62) From $0.62 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/09/2025 12:42 PDT] Adicet Bio, Inc. (NASDAQ:ACET), Down By 100% ($0.63) From $0.63 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/09/2025 07:18 PDT] ACET Expected to Trade Down After Bearish Patterns Develop
• [04/08/2025 07:59 PDT] ACET Expected to Trade Down After Bearish Patterns Develop